Description
Global Early Access Program to Provide Tofersen To Patients With Amyotrophic Lateral Sclerosis (ALS) Associated With a Mutation in the Superoxide Dismutase 1 (SOD1) Gene
Location: CPMC (San Francisco)
Please contact: ClinicalResearch@sutterhealth.org about study Tofersen EAP